冠心病抗栓治疗.讲课教案.pptVIP

冠心病抗栓治疗 专家共识;前 言;抗血小板治疗 ;;阿司匹林;阿司匹林;ADP受体拮抗剂 ;;裸金属支架 1个月 雷帕霉素涂层支架 6 – 9个月 紫杉醇涂层支架 9-12个月;ADP受体拮抗剂的适应证扩展;CHARISMA 结果Primary Efficacy Results (MI/Stroke/CV Death) by Pre-Specified Entry Category;GPIIb/IIIa受体拮抗剂;GPIIb/IIIa受体拮抗剂;PCI;Composite of death, MI, or urgent TVR due to Myocardial Ischemia within 30 days (%) 8.9% vs 11.9%; relative risk [RR] 0.75 p=0.03;Abciximab therapy was associated with reductions in the primary endpoint among patients who were troponin positive at baseline (13.1% vs 18